290 related articles for article (PubMed ID: 10766176)
21. Mutagenesis of human adenosine deaminase to active forms that partially resist inhibition by pentostatin.
Ibrahim MM; Weber IT; Knudsen TB
Biochem Biophys Res Commun; 1995 Apr; 209(2):407-16. PubMed ID: 7733907
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
23. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
24. Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure.
Gao X; Blackburn MR; Knudsen TB
Teratology; 1994 Jan; 49(1):1-12. PubMed ID: 8171392
[TBL] [Abstract][Full Text] [Related]
25. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine.
Paine RM; Weston BJ; Clink HM; Kohn J; Neville AM; McGhee KG; Harrap KR
Cancer Treat Rep; 1981; 65(3-4):259-66. PubMed ID: 6972254
[TBL] [Abstract][Full Text] [Related]
26. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
Plagemann PG; Wohlhueter RM
Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine.
Helland S; Ueland PM
Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
[No Abstract] [Full Text] [Related]
29. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
30. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
31. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase.
Saitoh M; Nagai K; Nakagawa K; Yamamura T; Yamamoto S; Nishizaki T
Biochem Pharmacol; 2004 May; 67(10):2005-11. PubMed ID: 15130776
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
[TBL] [Abstract][Full Text] [Related]
33. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
34. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
Wolberg G; Zimmerman TP
Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
[TBL] [Abstract][Full Text] [Related]
35. Early postimplantation embryolethality in mice following in utero inhibition of adenosine deaminase with 2'-deoxycoformycin.
Knudsen TB; Gray MK; Church JK; Blackburn MR; Airhart MJ; Kellems RE; Skalko RG
Teratology; 1989 Dec; 40(6):615-26. PubMed ID: 2623648
[TBL] [Abstract][Full Text] [Related]
36. Role of S-adenosylhomocysteine hydrolase in adenosine-induced apoptosis in HepG2 cells.
Hermes M; Osswald H; Kloor D
Exp Cell Res; 2007 Jan; 313(2):264-83. PubMed ID: 17097637
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety.
Long MC; Parker WB
Biochem Pharmacol; 2006 Jun; 71(12):1671-82. PubMed ID: 16620788
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.
Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS
J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636
[TBL] [Abstract][Full Text] [Related]
39. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
Duan DS; Smith W; Sadée W; Cowan MJ
Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
[TBL] [Abstract][Full Text] [Related]
40. Z-4',5'-didehydro-5'-deoxy-5'-fluoroadenosine (MDL 28,842), an irreversible inhibitor of S-adenosylhomocysteine hydrolase, suppresses proliferation of cultured keratinocytes and squamous carcinoma cell lines.
Paller AS; Arnsmeier SL; Clark SH; Mirkin BL
Cancer Res; 1993 Dec; 53(24):6058-60. PubMed ID: 8261422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
